Global Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 04-Oct-2022
No. of pages: 107
Inquire Before Buying

Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Cell Therapy market is projected to reach US$ 250460 million by 2028 from an estimated US$ 117160 million in 2022, at a CAGR of 13.5% during 2023 and 2028.

The classification of Cell Therapy includes Stem Cell therapy and Non-Stem Cell therapy, and the revenue proportion of Stem Cell therapy in 2019 is about 98.76%.

Cell Therapy is widely used in Hospital, Clinics and Other. The most proportion of Cell Therapy is Hospital, and the proportion in 2019 is about 77.2%.

North Americas is the largest consumption place, with a consumption market share nearly 43.65% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 35.41%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Cell Therapy.

The Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Cell Therapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Gilead Sciences

- Novartis

- Osiris

- Vericel Corporation

- Vcanbio

- Fujifilm Cellular Dynamics

- JCR Pharmaceuticals

- Beike Biotechnology

- Golden Meditech

- Guanhao Biotech

Product Type Insights

Global markets are presented by Cell Therapy type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Cell Therapy are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Cell Therapy Segment by Type

- Stem Cell

- Non-Stem Cell

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Cell Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Cell Therapy market.

Cell Therapy Segment by Application

- Hospital

- Clinic

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Cell Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Cell Therapy industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Global Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Cell Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Cell Therapy Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cell Therapy Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cell Therapy Market Size Estimates and Forecasts
2.2 Cell Therapy Market Size by Region: 2022 Versus 2028
2.2.1 Global Cell Therapy Revenue by Region: 2017-2022
2.2.2 Global Cell Therapy Revenue Forecast by Region (2023-2028)
2.2.3 Global Cell Therapy Revenue Market Share by Region (2017-2028)
3 Global Cell Therapy by Company
3.1 Global Cell Therapy Revenue by Company (2017-2022)
3.2 Global Cell Therapy Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Cell Therapy Companies around the World: Ranking by Revenue
3.3.2 Global Cell Therapy Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Cell Therapy Companies Headquarters & Product Type
3.4.1 Cell Therapy Companies Headquarters
3.4.2 Global Cell Therapy Companies Product & Service
3.4.3 Date of International Companies Enter into Cell Therapy Market
3.5 Global Cell Therapy Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Gilead Sciences
4.1.1 Gilead Sciences Corporation Information
4.1.2 Gilead Sciences Description, Business Overview
4.1.3 Gilead Sciences Cell Therapy Products Offered
4.1.4 Gilead Sciences Cell Therapy Revenue and Gross Margin (2017-2022)
4.1.5 Gilead Sciences Cell Therapy Revenue by Product in 2021
4.1.6 Gilead Sciences Cell Therapy Revenue by Application in 2021
4.1.7 Gilead Sciences Cell Therapy Revenue by Geographic Area in 2021
4.1.8 Gilead Sciences Recent Developments
4.2 Novartis
4.2.1 Novartis Corporation Information
4.2.2 Novartis Description, Business Overview
4.2.3 Novartis Cell Therapy Products Offered
4.2.4 Novartis Cell Therapy Revenue and Gross Margin (2017-2022)
4.2.5 Novartis Cell Therapy Revenue by Product in 2021
4.2.6 Novartis Cell Therapy Revenue by Application in 2021
4.2.7 Novartis Cell Therapy Revenue by Geographic Area in 2021
4.2.8 Novartis Recent Developments
4.3 Osiris
4.3.1 Osiris Corporation Information
4.3.2 Osiris Description, Business Overview
4.3.3 Osiris Cell Therapy Products Offered
4.3.4 Osiris Cell Therapy Revenue and Gross Margin (2017-2022)
4.3.5 Osiris Cell Therapy Revenue by Product in 2021
4.3.6 Osiris Cell Therapy Revenue by Application in 2021
4.3.7 Osiris Cell Therapy Revenue by Geographic Area in 2021
4.3.8 Osiris Recent Developments
4.4 Vericel Corporation
4.4.1 Vericel Corporation Corporation Information
4.4.2 Vericel Corporation Description, Business Overview
4.4.3 Vericel Corporation Cell Therapy Products Offered
4.4.4 Vericel Corporation Cell Therapy Revenue and Gross Margin (2017-2022)
4.4.5 Vericel Corporation Cell Therapy Revenue by Product in 2021
4.4.6 Vericel Corporation Cell Therapy Revenue by Application in 2021
4.4.7 Vericel Corporation Cell Therapy Revenue by Geographic Area in 2021
4.4.8 Vericel Corporation Recent Developments
4.5 Vcanbio
4.5.1 Vcanbio Corporation Information
4.5.2 Vcanbio Description, Business Overview
4.5.3 Vcanbio Cell Therapy Products Offered
4.5.4 Vcanbio Cell Therapy Revenue and Gross Margin (2017-2022)
4.5.5 Vcanbio Cell Therapy Revenue by Product in 2021
4.5.6 Vcanbio Cell Therapy Revenue by Application in 2021
4.5.7 Vcanbio Cell Therapy Revenue by Geographic Area in 2021
4.5.8 Vcanbio Recent Developments
4.6 Fujifilm Cellular Dynamics
4.6.1 Fujifilm Cellular Dynamics Corporation Information
4.6.2 Fujifilm Cellular Dynamics Description, Business Overview
4.6.3 Fujifilm Cellular Dynamics Cell Therapy Products Offered
4.6.4 Fujifilm Cellular Dynamics Cell Therapy Revenue and Gross Margin (2017-2022)
4.6.5 Fujifilm Cellular Dynamics Cell Therapy Revenue by Product in 2021
4.6.6 Fujifilm Cellular Dynamics Cell Therapy Revenue by Application in 2021
4.6.7 Fujifilm Cellular Dynamics Cell Therapy Revenue by Geographic Area in 2021
4.6.8 Fujifilm Cellular Dynamics Recent Development
4.7 JCR Pharmaceuticals
4.7.1 JCR Pharmaceuticals Corporation Information
4.7.2 JCR Pharmaceuticals Description, Business Overview
4.7.3 JCR Pharmaceuticals Cell Therapy Products Offered
4.7.4 JCR Pharmaceuticals Cell Therapy Revenue and Gross Margin (2017-2022)
4.7.5 JCR Pharmaceuticals Cell Therapy Revenue by Product in 2021
4.7.6 JCR Pharmaceuticals Cell Therapy Revenue by Application in 2021
4.7.7 JCR Pharmaceuticals Cell Therapy Revenue by Geographic Area in 2021
4.7.8 JCR Pharmaceuticals Recent Development
4.8 Beike Biotechnology
4.8.1 Beike Biotechnology Corporation Information
4.8.2 Beike Biotechnology Description, Business Overview
4.8.3 Beike Biotechnology Cell Therapy Products Offered
4.8.4 Beike Biotechnology Cell Therapy Revenue and Gross Margin (2017-2022)
4.8.5 Beike Biotechnology Cell Therapy Revenue by Product in 2021
4.8.6 Beike Biotechnology Cell Therapy Revenue by Application in 2021
4.8.7 Beike Biotechnology Cell Therapy Revenue by Geographic Area in 2021
4.8.8 Beike Biotechnology Recent Development
4.9 Golden Meditech
4.9.1 Golden Meditech Corporation Information
4.9.2 Golden Meditech Description, Business Overview
4.9.3 Golden Meditech Cell Therapy Products Offered
4.9.4 Golden Meditech Cell Therapy Revenue and Gross Margin (2017-2022)
4.9.5 Golden Meditech Cell Therapy Revenue by Product in 2021
4.9.6 Golden Meditech Cell Therapy Revenue by Application in 2021
4.9.7 Golden Meditech Cell Therapy Revenue by Geographic Area in 2021
4.9.8 Golden Meditech Recent Development
4.10 Guanhao Biotech
4.10.1 Guanhao Biotech Corporation Information
4.10.2 Guanhao Biotech Description, Business Overview
4.10.3 Guanhao Biotech Cell Therapy Products Offered
4.10.4 Guanhao Biotech Cell Therapy Revenue and Gross Margin (2017-2022)
4.10.5 Guanhao Biotech Cell Therapy Revenue by Product in 2021
4.10.6 Guanhao Biotech Cell Therapy Revenue by Application in 2021
4.10.7 Guanhao Biotech Cell Therapy Revenue by Geographic Area in 2021
4.10.8 Guanhao Biotech Recent Development
5 Breakdown Data by Type
5.1 Global Cell Therapy Revenue by Type (2017-2022)
5.2 Global Cell Therapy Revenue Forecast by Type (2023-2028)
5.3 Cell Therapy Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Cell Therapy Revenue by Application (2017-2022)
6.2 Global Cell Therapy Revenue Forecast by Application (2023-2028)
6.3 Cell Therapy Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Cell Therapy Market Size YoY Growth 2017-2028
7.2 North America Cell Therapy Market Facts & Figures by Country (2017-2028)
7.3 North America Cell Therapy Revenue by Type (2017-2022)
7.4 North America Cell Therapy Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Cell Therapy Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Cell Therapy Revenue by Type (2017-2022)
8.4 Asia-Pacific Cell Therapy Revenue by Application (2017-2022)
9 Europe
9.1 Europe Cell Therapy Market Size YoY Growth 2017-2028
9.2 Europe Cell Therapy Market Facts & Figures by Country (2017-2028)
9.3 Europe Cell Therapy Revenue by Type (2017-2022)
9.4 Europe Cell Therapy Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Cell Therapy Market Size YoY Growth 2017-2028
10.2 Latin America Cell Therapy Market Facts & Figures by Country (2017-2028)
10.3 Latin America Cell Therapy Revenue by Type (2017-2022)
10.4 Latin America Cell Therapy Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Cell Therapy Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Cell Therapy Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Cell Therapy Revenue by Type (2017-2022)
11.4 Middle East and Africa Cell Therapy Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Cell Therapy Supply Chain Analysis
12.2 Cell Therapy Key Raw Materials and Upstream Suppliers
12.3 Cell Therapy Clients Analysis
12.4 Cell Therapy Sales Channel and Sales Model Analysis
12.4.1 Cell Therapy Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Cell Therapy Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Cell Therapy Distributors
13 Market Dynamics
13.1 Cell Therapy Industry Trends
13.2 Cell Therapy Market Drivers
13.3 Cell Therapy Market Challenges
13.4 Cell Therapy Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Cell Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Stem Cell
Table 3. Major Companies of Non-Stem Cell
Table 4. Global Cell Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Cell Therapy Market Size by Region (US$ Million): 2022 VS 2028
Table 6. Global Cell Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Cell Therapy Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 8. Cell Therapy Revenue by Company (2017-2022) & (US$ Million)
Table 9. Cell Therapy Revenue Share by Company (2017-2022)
Table 10. Ranking of Global Top Cell Therapy Players by Revenue (US$ Million) in 2021
Table 11. Global Cell Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 12. Global Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell Therapy as of 2021)
Table 13. Global Cell Therapy Companies Headquarters
Table 14. Global Cell Therapy Companies Product & Service
Table 15. Date of International Companies Enter into Cell Therapy Market
Table 16. Global Cell Therapy Mergers & Acquisitions, Expansion Plans
Table 17. Gilead Sciences Corporation Information
Table 18. Gilead Sciences Description and Business Overview
Table 19. Gilead Sciences Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 20. Gilead Sciences Cell Therapy Product
Table 21. Gilead Sciences Cell Therapy Revenue Proportion of Cell Therapy by Product in 2021
Table 22. Gilead Sciences Cell Therapy Revenue Proportion of Cell Therapy by Application in 2021
Table 23. Gilead Sciences Cell Therapy Revenue Proportion of Cell Therapy by Geographic Area in 2021
Table 24. Gilead Sciences Recent Development
Table 25. Novartis Corporation Information
Table 26. Novartis Description and Business Overview
Table 27. Novartis Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 28. Novartis Cell Therapy Product
Table 29. Novartis Cell Therapy Revenue Proportion of Cell Therapy by Product in 2021
Table 30. Novartis Cell Therapy Revenue Proportion of Cell Therapy by Application in 2021
Table 31. Novartis Cell Therapy Revenue Proportion of Cell Therapy by Geographic Area in 2021
Table 32. Novartis Recent Development
Table 33. Osiris Corporation Information
Table 34. Osiris Description and Business Overview
Table 35. Osiris Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 36. Osiris Cell Therapy Product
Table 37. Osiris Cell Therapy Revenue Proportion of Cell Therapy by Product in 2021
Table 38. Osiris Cell Therapy Revenue Proportion of Cell Therapy by Application in 2021
Table 39. Osiris Cell Therapy Revenue Proportion of Cell Therapy by Geographic Area in 2021
Table 40. Osiris Recent Development
Table 41. Vericel Corporation Corporation Information
Table 42. Vericel Corporation Description and Business Overview
Table 43. Vericel Corporation Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 44. Vericel Corporation Cell Therapy Product
Table 45. Vericel Corporation Cell Therapy Revenue Proportion of Cell Therapy by Product in 2021
Table 46. Vericel Corporation Cell Therapy Revenue Proportion of Cell Therapy by Application in 2021
Table 47. Vericel Corporation Cell Therapy Revenue Proportion of Cell Therapy by Geographic Area in 2021
Table 48. Vericel Corporation Recent Development
Table 49. Vcanbio Corporation Information
Table 50. Vcanbio Description and Business Overview
Table 51. Vcanbio Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 52. Vcanbio Cell Therapy Product
Table 53. Vcanbio Cell Therapy Revenue Proportion of Cell Therapy by Product in 2021
Table 54. Vcanbio Cell Therapy Revenue Proportion of Cell Therapy by Application in 2021
Table 55. Vcanbio Cell Therapy Revenue Proportion of Cell Therapy by Geographic Area in 2021
Table 56. Vcanbio Recent Development
Table 57. Fujifilm Cellular Dynamics Corporation Information
Table 58. Fujifilm Cellular Dynamics Description and Business Overview
Table 59. Fujifilm Cellular Dynamics Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 60. Fujifilm Cellular Dynamics Cell Therapy Product
Table 61. Fujifilm Cellular Dynamics Cell Therapy Revenue Proportion of Cell Therapy by Product in 2021
Table 62. Fujifilm Cellular Dynamics Cell Therapy Revenue Proportion of Cell Therapy by Application in 2021
Table 63. Fujifilm Cellular Dynamics Cell Therapy Revenue Proportion of Cell Therapy by Geographic Area in 2021
Table 64. JCR Pharmaceuticals Corporation Information
Table 65. JCR Pharmaceuticals Description and Business Overview
Table 66. JCR Pharmaceuticals Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 67. JCR Pharmaceuticals Cell Therapy Product
Table 68. JCR Pharmaceuticals Cell Therapy Revenue Proportion of Cell Therapy by Product in 2021
Table 69. JCR Pharmaceuticals Cell Therapy Revenue Proportion of Cell Therapy by Application in 2021
Table 70. JCR Pharmaceuticals Cell Therapy Revenue Proportion of Cell Therapy by Geographic Area in 2021
Table 71. Beike Biotechnology Corporation Information
Table 72. Beike Biotechnology Description and Business Overview
Table 73. Beike Biotechnology Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 74. Beike Biotechnology Cell Therapy Product
Table 75. Beike Biotechnology Cell Therapy Revenue Proportion of Cell Therapy by Product in 2021
Table 76. Beike Biotechnology Cell Therapy Revenue Proportion of Cell Therapy by Application in 2021
Table 77. Beike Biotechnology Cell Therapy Revenue Proportion of Cell Therapy by Geographic Area in 2021
Table 78. Golden Meditech Corporation Information
Table 79. Golden Meditech Description and Business Overview
Table 80. Golden Meditech Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 81. Golden Meditech Cell Therapy Product
Table 82. Golden Meditech Cell Therapy Revenue Proportion of Cell Therapy by Product in 2021
Table 83. Golden Meditech Cell Therapy Revenue Proportion of Cell Therapy by Application in 2021
Table 84. Golden Meditech Cell Therapy Revenue Proportion of Cell Therapy by Geographic Area in 2021
Table 85. Guanhao Biotech Corporation Information
Table 86. Guanhao Biotech Description and Business Overview
Table 87. Guanhao Biotech Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 88. Guanhao Biotech Cell Therapy Product
Table 89. Guanhao Biotech Cell Therapy Revenue Proportion of Cell Therapy by Product in 2021
Table 90. Guanhao Biotech Cell Therapy Revenue Proportion of Cell Therapy by Application in 2021
Table 91. Guanhao Biotech Cell Therapy Revenue Proportion of Cell Therapy by Geographic Area in 2021
Table 92. Global Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 93. Global Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 94. Global Cell Therapy Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 95. North America Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 96. North America Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 97. North America Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 98. North America Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 99. Asia-Pacific Cell Therapy Revenue by Region (2017-2028) & (US$ Million)
Table 100. Asia-Pacific Cell Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 101. Asia-Pacific Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 102. Asia-Pacific Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 103. Europe Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 104. Europe Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 105. Europe Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 106. Europe Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 107. Latin America Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 108. Latin America Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 109. Latin America Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 110. Latin America Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 113. Middle East and Africa Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 114. Middle East and Africa Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 115. Cell Therapy Key Raw Materials, Industry Status and Trend
Table 116. Cell Therapy Key Raw Materials and Upstream Suppliers
Table 117. Cell Therapy Clients Status and Trend
Table 118. Cell Therapy Typical Clients
Table 119. Cell Therapy Distributors
Table 120. Cell Therapy Market Trends
Table 121. Cell Therapy Market Drivers
Table 122. Cell Therapy Market Challenges
Table 123. Cell Therapy Market Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Cell Therapy Product Picture
Figure 2. Global Cell Therapy Revenue Market Share by Type in 2021 & 2028
Figure 3. Stem Cell Product Picture
Figure 4. Non-Stem Cell Product Picture
Figure 5. Global Cell Therapy Revenue Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Cell Therapy Report Years Considered
Figure 9. Global Cell Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Cell Therapy Market Size 2017-2028 (US$ Million)
Figure 11. Global Cell Therapy Market Size Market Share by Region: 2022 Versus 2028
Figure 12. Global Cell Therapy Revenue Market Share by Region (2017-2028)
Figure 13. Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Cell Therapy Revenue Market Share Forecast by Type (2017-2028)
Figure 15. Global Cell Therapy Revenue Market Share Forecast by Application (2017-2028)
Figure 16. North America Cell Therapy Revenue 2017-2028 (US$ Million)
Figure 17. North America Cell Therapy Revenue Market Share by Type (2017-2022)
Figure 18. North America Cell Therapy Revenue Market Share by Application (2017-2022)
Figure 19. Asia-Pacific Cell Therapy Revenue 2017-2028 (US$ Million)
Figure 20. Asia-Pacific Cell Therapy Revenue Market Share by Region (2017-2028)
Figure 21. Asia-Pacific Cell Therapy Revenue Market Share by Type (2017-2022)
Figure 22. Asia-Pacific Cell Therapy Revenue Market Share by Application (2017-2022)
Figure 23. Europe Cell Therapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 24. Europe Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 25. Europe Cell Therapy Revenue Market Share by Type (2017-2022)
Figure 26. Europe Cell Therapy Revenue Market Share by Application (2017-2022)
Figure 27. Latin America Cell Therapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 28. Latin America Cell Therapy Revenue Market Share by Country (2017-2022)
Figure 29. Latin America Cell Therapy Revenue Market Share by Type (2017-2022)
Figure 30. Latin America Cell Therapy Revenue Market Share by Application (2017-2022)
Figure 31. Middle East and Africa Cell Therapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 32. Middle East and Africa Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 33. Middle East and Africa Cell Therapy Revenue Market Share by Type (2017-2022)
Figure 34. Middle East and Africa Cell Therapy Revenue Market Share by Application (2017-2022)
Figure 35. Cell Therapy Supply Chain (Upstream and Downstream Market)
Figure 36. Global Production Market Share of Cell Therapy Raw Materials by Region in 2021
Figure 37. Cell Therapy Distribution Channels
Figure 38. Global Cell Therapy Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 39. Global Cell Therapy Percentage 2017-2028: Online Sales VS Offline Sales
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed
  • Global Cytokine Inhibitor Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Cytokine Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The development prospects of cytokine inhibitors are very broad, and these drugs have many medical applications and researches. Cytokine inhibitors can reduce The activity of cytokines, thereby inhibiting their role in immune responses and reducing The activation of immune cells and The occurrence o......
  • Global Microbial Growth Media Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Microbial Growth Media is a nutrient component required by microorganisms, containing a variety of trace elements and trace elements, such as copper, iron, zinc, cobalt, manganese, etc. The global Microbial Growth Media market was valued at US$ 8007 million in 2023 and is anticipated to reach US$ 11530 million by 2030, witnessing a CAGR of 5.3% during The forecast period 2024-2030. The market for microbial growth media is essential in microbiology and biotechnology rese......
  • Global Protein Biochip Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    Protein Biochip is a small Protein array used to quickly detect a large number of unknown proteins. It works in a similar way to a DNA chip. First, a large number of known proteins (such as monoclonal antibodies) are placed on a small substrate and then exposed to and reacted with The unknown protein sample. Due to The specific binding between The antigen and The antibody, it can finally be detected by means of laser. The global Protein Biochip market was valued at US$ 145 million i......
  • Global Isothermal Nucleic Acid Amplification Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 103
    Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get The statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish The reaction. T......
  • Global Microfluidics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Microfluidics market size was valued at US$ 3118.7 million in 2023. With growing demand in downstream market, the Microfluidics is forecast to a readjusted size of US$ 7707.1 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Microfluidics market. Microfluidics are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 122
    According to our LPI (LP Information) latest study, the global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at US$ 6141.3 million in 2023. With growing demand in downstream market, the Isothermal Nucleic Acid Amplification Technology (INAAT) is forecast to a readjusted size of US$ 11250 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Isothermal Nucleic Acid Amplification Technol......
  • Global Cytokines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Cytokines market size was valued at US$ 203730 million in 2023. With growing demand in downstream market, the Cytokines is forecast to a readjusted size of US$ 611910 million by 2030 with a CAGR of 17.0% during review period. The research report highlights the growth potential of the global Cytokines market. Cytokines are expected to show stable growth in the future market. However, product differentiation, reducing costs, an......
  • Global Western Blot Imagers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Western Blot Imagers market size was valued at US$ 406 million in 2023. With growing demand in downstream market, the Western Blot Imagers is forecast to a readjusted size of US$ 578.4 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Western Blot Imagers market. Western Blot Imagers are expected to show stable growth in the future market. However, prod......
  • Global Procalcitonin Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Procalcitonin Antibody market size was valued at US$ million in 2023. With growing demand in downstream market, the Procalcitonin Antibody is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Procalcitonin Antibody market. Procalcitonin Antibody are expected to show stable growth in the future market. However, product di......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs